HyperBaric Systems: Blood Platelet Validation Tests Set For Completion In October
siliconinvestor.com
PALO ALTO, Calif., Oct 16, 2001 (BUSINESS WIRE) -- HyperBaric Systems (OTC: HYRB chart, msgs) is in the final process of completing its extended platelet preservation tests at the Blood Research Center in Sacramento.
The results of a variety of platelet preservation tests utilizing HyperBaric's proprietary cold storage technology were originally scheduled to be announced in September.
"The final tests were delayed a few weeks primarily due to a shortage of specific ingredients and the attacks on the New York World Trade Center," Harry Masuda, HyperBaric Systems President, said. "All of the results will be announced in October or early November."
Dr. David Lucas, HyperBaric Scientific Director said, "We are very happy with the test results to date. They have confirmed our findings."
"We are anticipating the ten day results will further confirm our internal testing."
Dr. Lucas also stated that he is developing a protocol and pursuing arrangements to have human infusion tests started within the next ninety days. "This is an important step in our product development path," he said.
Currently blood platelets are stored at room temperature for a maximum period of five days.
"Not only does our technology double the current shelf life of blood platelets, it virtually eliminates the growth of bacteria," Dr. Lucas said.
Bacterial contamination is generally considered to be one of the most critical problems associated with blood platelet storage and infusion today.
"The process and methodology of our proprietary cold storage system, which includes a complex high-speed temperature reduction, maintains fresher and safer platelets," Dr. Lucas stated.
"We believe cold storage is best for platelets just as it is for the storage of milk. Obviously a refrigerated carton of milk is safer and better than one left at room temperature," he said.
"We are very excited about our breakthrough technology," Dr. Lucas said. "Not only will we save the industry millions of dollars in inventory control and outdating problems, we will help blood centers save millions of lives worldwide."
HyperBaric Systems is a three and a half year old company headquartered in Palo Alto California with research facilities in Michigan and Russia.
Certain statements contained herein are "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those discussed in filings made by the Company with the Securities and Exchange Commission. |
